CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 12.8: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
6.57%
Annual Rate
CNY 1.60Paid semi-annual
Payout Ratio
206.4%High
Payback Period
19.1 yr
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.00BCNY299.22M · vs all stocks (USD)
Trailing P/E
39.21xvs Medical Instruments & Supplies peers
Revenue (TTM)
283.90MCNY42.38M · vs all stocks (USD)
Profit Margin
17.86%vs Medical Instruments & Supplies peers
Beta
0.2290xvs all stocks
52-Week Change
-58.83%vs all stocks
Forward Annual Dividend Yield
6.57%vs all stocks
Market Capitalization
2.00BCNY299.22M · vs all stocks (USD)
Enterprise Value
1.78BCNY264.99M · vs all stocks (USD)
Trailing P/E
39.21xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
7.06xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
4.00xvs Medical Instruments & Supplies peers
Enterprise to Revenue
6.25xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
32.78xvs Medical Instruments & Supplies peers
Gross Margin
60.32%vs Medical Instruments & Supplies peers
Profit Margin
17.86%vs Medical Instruments & Supplies peers
Operating Margin
4.52%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
4.06%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
9.49%vs Medical Instruments & Supplies peers
Revenue (TTM)
283.90MCNY42.38M · vs all stocks (USD)
Revenue per Share (TTM)
3.52CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-36.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
180.60MCNY26.96M · vs all stocks (USD)
EBITDA (TTM)
101.34MCNY15.13M · vs all stocks (USD)
Net Income (TTM)
50.71MCNY7.57M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-88.40%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
41.84MCNY6.25M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-47.16MCNY-7.04M · vs all stocks (USD)
Forward Annual Dividend Rate
1.60CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
6.57%vs all stocks
Trailing Annual Dividend Rate
1.30CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
5.34%vs all stocks
Payout Ratio
206.35%vs Medical Instruments & Supplies peers
Revenue
326.73MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
117.87MCNYFY2025 · Dec 31, 2025Gross Profit
208.86MCNYFY2025 · Dec 31, 2025Operating Income
75.63MCNY11.29M · vs all stocks (USD)
Pre-tax Income
95.17MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.98MCNYFY2025 · Dec 31, 2025Net Income
85.19MCNYFY2025 · Dec 31, 2025EBIT
95.64MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
101.34MCNYFY2025 · Dec 31, 2025Research & Development
51.30MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
36.08MCNYFY2025 · Dec 31, 2025Other Operating Expenses
3.54MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
103.38KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
473.45KCNYFY2025 · Dec 31, 2025EPS (Basic)
1.06CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.05CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
80.36MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
80.36MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
85.19MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
46.36MCNYFY2025 · Dec 31, 2025Free Cash Flow
-43.91MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
98.78MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
85.19MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-10.06MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-26.28MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-2.49MCNYFY2025 · Dec 31, 2025Capital Expenditures
-90.27MCNYFY2025 · Dec 31, 2025Purchase of Investments
-436.00MCNYFY2025 · Dec 31, 2025Sale of Investments
552.67MCNYFY2025 · Dec 31, 2025Other Investing Activity
-8.88MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
17.52MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
80.39MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-31.89MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-121.58MCNYFY2025 · Dec 31, 2025Other Financing Charges
12.38MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-60.70MCNYFY2025 · Dec 31, 2025Shares Outstanding
81.16MSharesUpdated Sep 22, 2026Float Shares
34.72MSharesUpdated Sep 22, 2026% Held by Insiders
56.46%vs all stocks
% Held by Institutions
3.56%vs all stocks
Total Cash (MRQ)
252.09MCNY37.63M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.15CNYUpdated Sep 22, 2026Total Debt (MRQ)
130.96MCNY19.55M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2647xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.50xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.18CNYUpdated Sep 22, 2026Total Assets
672.93MCNY100.45M · vs all stocks (USD)
Total Current Assets
376.92MCNYFY2025 · Dec 31, 2025Total Liabilities
107.37MCNYFY2025 · Dec 31, 2025Total Non-current Assets
296.01MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
19.74MCNYFY2025 · Dec 31, 2025Total Current Liabilities
87.63MCNYFY2025 · Dec 31, 2025Cash
98.78MCNYFY2025 · Dec 31, 2025Cash Equivalents
24.06MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
122.84MCNYFY2025 · Dec 31, 2025Other Short-term Investments
171.16MCNYFY2025 · Dec 31, 2025Accounts Receivable
42.25MCNYFY2025 · Dec 31, 2025Inventory
34.07MCNYFY2025 · Dec 31, 2025Accounts Payable
9.67MCNYFY2025 · Dec 31, 2025Short-term Debt
35.46MCNYFY2025 · Dec 31, 2025Other Current Liabilities
634.05KCNYFY2025 · Dec 31, 2025Long-term Debt
15.00MCNYFY2025 · Dec 31, 2025Common Stock (Book)
81.16MCNYFY2025 · Dec 31, 2025Retained Earnings
61.66MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
565.55MCNY84.42M · vs all stocks (USD)
Treasury Stock
15.60MCNYFY2025 · Dec 31, 202552-Week Low
21.11CNYUpdated Sep 22, 202652-Week High
63.00CNYUpdated Sep 22, 202652-Week Change
-58.83%vs all stocks
Beta
0.2290xvs all stocks
50-Day MA
24.28CNYUpdated Sep 22, 2026200-Day MA
34.66CNYUpdated Sep 22, 2026Avg 10-Day Volume
1.17MSharesUpdated Sep 22, 2026Avg 30-Day Volume
1.20MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.6300CNYUpdated Sep 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 2.06Dividend per Share: 1.30Earnings per Share: 0.63
Financial Health
Altman Z-Score 12.8: safe zoneNotable
Altman Z-Score: 12.80
High earnings qualityNotable
Earnings Quality Score: 0.51
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Anhui Sentai WPC Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Friendcom Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
China Metal Products Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Holley Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhuzhou Feilu High-tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Ulusoy Elektrik İmalat Taahhüt A.Ş.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Myoung Shin Industrial Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Airjoule Technologies Corp.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jiangsu Zhongsheng Gaoke Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Yantai Yatong Precision Manufacturing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Advanced Enzyme Technologies Ltd.
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated
Netflix, Inc.
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated
Kingnet Network Co., Ltd.
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated